Cybin Shareholders Vote on Rebrand to Helus Pharma, Eight-Member Board

Cybin Inc. (NASDAQ:HELP), operating as Helus Pharma, asked shareholders to back a rebrand to Helus Pharma Inc., an eight-member board, Zeifmans LLP as auditor and eight director nominees at its AGM.